A Kansas law compels drugmakers to extend 340B program discounts to contract pharmacies. In early July, AstraZeneca and AbbVie filed lawsuits against the legislation, according to court documents obtained by Becker's.
AbbVie said contract pharmacies have used the law, Senate Bill 28, to "acquire manufacturers' drugs at the federally discounted price, sell them to patients (including indigent patients) at full price, and pocket the difference."
The two pharmaceutical companies challenged the constitutionality of the law and are seeking to nullify it.